Tumor microenvironment-driven drug resistance in urologic cancers: mechanisms and therapeutic targets
{{output}}
Therapeutic resistance remains a major challenge in the management of urologic cancers, including renal cell carcinoma (RCC), bladder cancer (BC), and prostate cancer (PCa). Recent advances highlight the tumor microenvironment (TME) as a critical determinant o... ...
